Skip to main content
. 2011 Jun 20;32(7):956–966. doi: 10.1038/aps.2011.33

Table 3. Effects of diabetes on Rho123 distribution in cerebral cortex, hippocampus, liver, intestinal mucosa and kidney of experimental rats.

  Control Diabetes Diabetes+insulin
5-week
Plasma (ng/mL) 44.4±5.5 30.6±1.8c 45.6±4.0f
Cerebral cortex (ng/g) 4.28±0.14 5.15±0.43b 3.80±0.26f
Kp (cerebral cortex, mL/g) 0.09±0.01 0.17±0.01c 0.09±0.01f
Hippocampus (ng/g) 4.62±0.63 6.26±1.32 7.11±2.59
Kp (hippocampus, mL/g) 0.11±0.02 0.21±0.02c 0.14±0.06
Liver (ng/g) 52.5±17.3 187.1±47.5c 87.6±45.4f
Kp (liver, mL/g) 1.16±0.26 6.17±1.41c 1.87±0.87f
Intestinal mucosa (ng/g) 451 811±68 825 527 034±14 232 275 987±76 654b
Kp (intestinal mucosa, mL/g) 12 653±3375 17 345±1224 6308±1819bf
Kidney (ng/g) 784.2±237.7 976.9±114.9 594.4±195.3e
Kp (kidney, mL/g) 17.7±4.7 32.7±5.3c 13.3±5.1f
8-week
Plasma (ng/mL) 38.4±4.8 25.3±1.7c 40.7±0.7f
Cerebral cortex (ng/g) 4.04±0.34 3.19±0.26c 3.45±0.42
Kp (cerebral cortex, mL/g) 0.10±0.01 0.13±0.02 0.09±0.01f
Hippocampus (ng/g) 3.70±0.20 3.69±0.47 4.37±0.64
Kp (hippocampus, mL/g) 0.10±0.02 0.15±0.02c 0.11±0.02f
Liver (ng/g) 69.4±10.2 66.6± 6.2 120.9±34.1be
Kp (liver, ml/g) 1.77±0.11 2.70±0.27 2.98±0.85b
Intestinal mucosa (ng/g) 101 135±23 658 77 296±8577 210 123±55 354bf
Kp (intestinal mucosa, mL/g) 2777±366 3087±331 5170±1321
Kidney (ng/g) 422.5±103.2 149.3±34.1c 578.0±139.9bf
Kp (kidney, mL/g) 17.9±3.4 5.9±1.4c 14.2±3.2f

The insulin-treated rats (Diabetes+insulin) were subcutaneouly administered insulin at 10 U·kg−1·d−1 twice a day for consecutive 5 and 8 weeks. The STZ-induced diabetic rats (Diabetes) and age-matched normal control rats (Control) only received vehicle. The concentrations of Rho123 in plasma and tissues were measured at 45 min followed administration of Rho123 (0.2 mg/kg, iv). Each data represents the mean±SD of five rats. Intestinal mucosa was represented by ng/g protein, while brain, liver and kidney were represented by ng/g tissue. Kp represents the tissue-to-plasma concentration ratio. bP<0.05, cP<0.01 vs control group; eP<0.05, fP<0.01 vs diabetic group.